$SE

Here are the major earnings before the open Tuesday

The article lists companies scheduled to report earnings before the market opens Tuesday. It highlights Sea Limited (SE), Cardinal Health (CAH), Rackspace Technology (RXT), Organigram Global (OGI), and On Holding AG (ONON), and also notes additional tickers including AMBQ, AMTM, AP, ARMK, AUTL, BSIN, BWEN, CRNT, CWCO, and others.

Original reporting
Published Aug 10, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 11:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SE
Neutral
low confidence
Mentioned
$SE · $CAH · $RXT · $OGI · $ONON
Relevance
4/10
alphai data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$SENeutralLow
01

Why it matters

Because it only states which firms report before the open, it offers timing for event-risk trading but no new earnings or guidance information.

02

Market read

Traders can use the list to plan around scheduled earnings volatility, but there is no disclosed fundamental catalyst beyond timing.

03

What to watch

Actual price impact depends on consensus vs reported numbers, guidance, and margins, none of which are included in this text.

Relevance 4/10Novelty 1/10Timing: pre-market today, ahead of Tuesday’s open earnings prints

Background

The article is a pre-open earnings calendar listing several companies expected to report before Tuesday’s bell.

Company-level read

Ticker impact

$SENeutralLow confidence
Context

Sea Limited is listed as a major earnings release before the bell Tuesday, making it a near-term catalyst for traders.

Expected impact

Likely elevated pre-open volatility; direction uncertain without earnings specifics.

Evidence & confidence

The text is a calendar listing only, with no disclosed earnings figures, guidance, or surprises.

$CAHNeutralLow confidence
Context

Cardinal Health is flagged for earnings before Tuesday’s open, setting up a scheduled fundamental catalyst.

Expected impact

Event-driven volatility possible; direction not inferable from the listing.

Evidence & confidence

No earnings numbers, guidance, or analyst changes are included.

$RXTNeutralLow confidence
Context

Rackspace Technology is included in the major earnings expected before the bell Tuesday, implying near-term risk repricing.

Expected impact

Higher volatility around the open; no directional edge from this text.

Evidence & confidence

Only a release calendar is provided, not a fresh disclosure.

$OGINeutralLow confidence
Context

Organigram Global is listed among major earnings before Tuesday’s open, making it an identifiable event catalyst.

Expected impact

Potential gap risk at the open; direction unknown.

Evidence & confidence

The article contains no earnings content beyond the scheduled timing.

$ONONNeutralLow confidence
Context

On Holding AG is named for major earnings before the bell Tuesday, creating a specific pre-market catalyst.

Expected impact

Volatility likely into the open; direction not supported by the text.

Evidence & confidence

This is a multi-name earnings calendar with no disclosed earnings/guidance details.

Market effects

Broad earnings calendar can increase overall event-driven volatility across healthcare, retail/consumer, and tech-adjacent names, but no sector-specific facts are provided.

Primarily US pre-open event risk; no cross-region macro or policy linkage is described.

Limited, since the article is a US-focused earnings timing list with no global developments.

Counterpoint

A calendar listing alone often leads to crowded positioning, so realized moves may be smaller than expected unless results/guidance surprise.

Key entities

  • Sea Limited

    Named as a major earnings release before the bell Tuesday.

  • Cardinal Health

    Named as a major earnings release before the bell Tuesday.

  • Rackspace Technology

    Named as a major earnings release before the bell Tuesday.

  • Organigram Global

    Named as a major earnings release before the bell Tuesday.

  • On Holding AG

    Named as a major earnings release before the bell Tuesday.

Related articles

$RXTLow

RXT Deadline Approaching: BFA Law Notifies Rackspace Investors Who Suffered Losses of Ongoing Securities Fraud Class Action and Upcoming September 28 Deadline

Bleichmar Fonti & Auld LLP announced a class action lawsuit against Rackspace Technology (RXT) and its executives for alleged securities fraud. The suit claims Rackspace misled investors about its AI efforts, leading to a 33.6% stock drop on July 9, 2026, after the company cut its revenue guidance by $150 million. Investors have until September 28, 2026, to join the lawsuit.

$OGIMed

Organigram Global Inc.: Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram Global Inc. (OGI) accelerated the integration of Sanity Group, aligning leadership and operations. Sanity contributed CAD 40 million (35% of revenue) in the last quarter, with revenue growing 34% to €25.5 million. The company amended the earnout agreement, fixing it at 85% of the maximum value, with €20 million in cash and €76 million in shares payable in 2027. New leadership roles were appointed to support global growth.

$CAHHighAI 9/10

Cardinal Health (CAH) Q4 2026 Earnings Call Transcript

Cardinal Health (CAH) reported Q4 2026 revenue of $63.7B, up 6%, driven by Pharmaceutical and Specialty Solutions. Non-GAAP EPS was $2.91, up 40%. Fiscal 2027 guidance includes 3-5% pharma revenue growth and 8-11% profit growth. The company plans $1B in share repurchases and increased its authorization to $6.4B. Management cited risks from geopolitical instability and IRA price changes.

$OGIMedAI 8/10

Organigram (OGI) Q3 2026 Earnings Call Transcript

Organigram (OGI) reported Q3 2026 revenue of $105.8M, up 49% YoY, driven by Sanity Group acquisition. Adjusted EBITDA rose 136% to $13.4M. International sales now 35% of total revenue. CEO Yamanaka highlighted strategic transformation and record THC potency. CFO Guyatt expects margins to exceed fiscal 2025 levels. The company faces EU supply constraints and U.S. regulatory uncertainty.